The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)
Abstract
Authors
JA de Anda C Noda P Anaya A Azamar M Machado P Serafini